IPI-145

A potent, bioavailable inhibitor of PI3K? and PI3Kd

Price Not Available 25 mg IPI-145 Supplier Page
Catalog Number 16800
Alternative Name(s) Duvelisib|INK1197
Research Area Product Type|Biochemicals|Kinase Inhibitors|PI3K||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cell Biology|Cell Signaling|PI3K/Akt/mTOR Signaling||Research Area|Immunology & Inflammation|Autoimmunity|Lupus||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma
Molecular Formula C22H17ClN6O
CAS# 1201438-56-3
Purity ≥98%
Inchi InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1
Inchi Key SJVQHLPISAIATJ-ZDUSSCGKSA-N
SMILES C[C@@H](C1=CC(C=CC=C2Cl)=C2C(N1C3=CC=CC=C3)=O)NC4=C5C(N=CN5)=NC=N4
Size 25 mg
Supplier Page https://www.caymanchem.com/product/16800